Seng-Gee Lim
机构: Professor of Medicine, National University Health System
每年引用次数
引用次数
引用: 32,882
H-指数: 83
I10-指数 : 251
出版物: 537
Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).
Henry LY Chan , Sang Hoon Ahn , Ting-Tsung Chang , Cheng-Yuan Peng
Journal of Hepatology 64 ( 5) 1011 -1019
43
2016
Engineering virus-specific T cells that target HBV infected hepatocytes and hepatocellular carcinoma cell lines
Adam J. Gehring , Shao-An Xue , Zi Zong Ho , Denise Teoh
Journal of Hepatology 55 ( 1) 103 -110
157
2011
Increased viral quasispecies evolution in HBeAg seroconverter patients treated with oral nucleoside therapy
Yan Cheng , Stephane Guindon , Allen Rodrigo , Seng Gee Lim
Journal of Hepatology 58 ( 2) 217 -224
26
2013
Reduction of HBV replication prolongs the early immunological response to IFNα therapy.
Anthony T. Tan , Long Truong Hoang , Daniel Chin , Erik Rasmussen
Journal of Hepatology 60 ( 1) 54 -61
61
2014
Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy.
Patrick Marcellin , Karsten Wursthorn , Heiner Wedemeyer , Wan-Long Chuang
Journal of Hepatology 62 ( 1) 41 -47
50
2015
Clinical outcomes of lamivudine-adefovir therapy in chronic hepatitis B cirrhosis.
Seng Gee Lim , Myat Oo Aung , Belinda Mak , Dede Sutedja
Journal of Clinical Gastroenterology 45 ( 9) 818 -823
8
2011
Adefovir dipivoxil for the treatment of hepatitis B e antigen-positive chronic hepatitis B.
Patrick Marcellin , Ting-Tsung Chang , Seng Gee Lim , Myron J Tong
The New England Journal of Medicine 348 ( 9) 808 -816
2,007
2003
Adefovir Dipivoxil for the Treatment of Hepatitis B e Antigen–Negative Chronic Hepatitis B
Stephanos J. Hadziyannis , Nicolaos C. Tassopoulos , E. Jenny Heathcote , Ting-Tsung Chang
The New England Journal of Medicine 348 ( 9) 800 -807
1,415
2003
Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B
Stephanos J. Hadziyannis , Nicolaos C. Tassopoulos , E. Jenny Heathcote , Ting-Tsung Chang
The New England Journal of Medicine 352 ( 26) 2673 -2681
475
2005
Sofosbuvir/Velpatasvir for Treatment of Hepatitis C Virus in Asia: An Open-Label, Phase 3 Study
Lai Wei , Seng Gee Lim , Qing Xie , Kinh Nguyen Van
Social Science Research Network
2018
CD4+ T Cells Mediate the Development of Liver Fibrosis in High Fat Diet-Induced NAFLD in Humanized Mice.
Zhisheng Her , Joel Heng Loong Tan , Yee-Siang Lim , Sue Yee Tan
Frontiers in Immunology 11 580968
42
2020
Characterisation of liver pathogenesis, human immune responses and drug testing in a humanised mouse model of HCV infection
Choong Tat Keng , Ching Wooen Sze , Dahai Zheng , Zhiqiang Zheng
Gut 65 ( 10) 1744 -1753
18
2016
Ethics and hepatitis B cure research
Jeremy Sugarman , Peter Revill , Fabien Zoulim , Yazdan Yazdanpanah
Gut 66 ( 3) 389 -392
11
2017
Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders
Kumar Visvanathan , Geoff Dusheiko , Michelle Giles , May-Ling Wong
Gut 65 ( 2) 340 -350
95
2016
The efficacy of hepatitis B treatments in achieving HBsAg seroclearance: A systematic review and meta-analysis.
Mariana Alves Fonseca , Joanna Zhi Jie Ling , Omar Al‐Siyabi , Vanessa Co‐Tanko
Journal of Viral Hepatitis 27 ( 7) 650 -662
3
2020
Findings from a large Asian chronic hepatitis C real-life study.
Seng Gee Lim , Wah Wah Phyo , Samir R Shah , Khin Maung Win
Journal of Viral Hepatitis 25 ( 12) 1533 -1542
6
2018
Therapeutic vaccination for chronic hepatitis B: A systematic review and meta‐analysis
Seng Gee Lim , Jennielyn Agcaoili , Nurun Nisa Amatullah De Souza , Edwin Chan
Journal of Viral Hepatitis 26 ( 7) 803 -817
14
2019
L-dT: An ongoing phase I/IIa dose-escalation trial in patients with chronic HBV infection (NV-02B-001)
Seng Gee Lim , Ching-Lung Lai , Yin-Mei Lee , Deborah M. Pow
Gastroenterology 120 ( 5)
2
2001
Clinical significance of hepatitis B virion and SVP productivity: relationships between intrahepatic and serum markers in chronic hepatitis B patients
Cosmas Rinaldi Adithya Lesmana , Kathy Jackson , Seng Gee Lim , Ali Sulaiman
United European gastroenterology journal 2 ( 2) 99 -107
8
2014
The hepatitis C virus core protein interacts with NS5A and activates its caspase-mediated proteolytic cleavage.
Phuay-Yee Goh , Yee-Joo Tan , Siew Pheng Lim , Seng Gee Lim
Virology 290 ( 2) 224 -236
55
2001